Literature DB >> 1383237

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth.

F Bussolino1, M F Di Renzo, M Ziche, E Bocchietto, M Olivero, L Naldini, G Gaudino, L Tamagnone, A Coffer, P M Comoglio.   

Abstract

Hepatocyte Growth Factor (HGF, also known as Scatter Factor) is a powerful mitogen or motility factor in different cells, acting through the tyrosine kinase receptor encoded by the MET protooncogene. Endothelial cells express the MET gene and expose at the cell surface the mature protein (p190MET) made of a 50 kD (alpha) subunit disulfide linked to a 145-kD (beta) subunit. HGF binding to endothelial cells identifies two sites with different affinities. The higher affinity binding site (Kd = 0.35 nM) corresponds to the p190MET receptor. Sub-nanomolar concentrations of HGF, but not of a recombinant inactive precursor, stimulate the receptor kinase activity, cell proliferation and motility. HGF induces repairs of a wound in endothelial cell monolayer. HGF stimulates the scatter of endothelial cells grown on three-dimensional collagen gels, inducing an elongated phenotype. In the rabbit cornea, highly purified HGF promotes neovascularization at sub-nanomolar concentrations. HGF lacks activities related to hemostasis-thrombosis, inflammation and endothelial cells accessory functions. These data show that HGF is an in vivo potent angiogenic factor and in vitro induces endothelial cells to proliferate and migrate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383237      PMCID: PMC2289675          DOI: 10.1083/jcb.119.3.629

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  72 in total

1.  The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs.

Authors:  R J Kaufman; M V Davies; V K Pathak; J W Hershey
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

2.  Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon.

Authors:  J S Pober; M A Gimbrone; L A Lapierre; D L Mendrick; W Fiers; R Rothlein; T A Springer
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

3.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

4.  Characterization of the mouse met proto-oncogene.

Authors:  A M Chan; H W King; E A Deakin; P R Tempest; J Hilkens; V Kroezen; D R Edwards; A J Wills; P Brookes; C S Cooper
Journal:  Oncogene       Date:  1988-06       Impact factor: 9.867

5.  Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment.

Authors:  R L Williams; W Risau; H G Zerwes; H Drexler; A Aguzzi; E F Wagner
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

6.  Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes.

Authors:  R Zarnegar; S Muga; R Rahija; G Michalopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Biosynthesis of the protein encoded by the c-met proto-oncogene.

Authors:  S Giordano; M F Di Renzo; R P Narsimhan; C S Cooper; C Rosa; P M Comoglio
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

8.  Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor.

Authors:  K Miyazawa; H Tsubouchi; D Naka; K Takahashi; M Okigaki; N Arakaki; H Nakayama; S Hirono; O Sakiyama; K Takahashi
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

9.  Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.

Authors:  R Zarnegar; G Michalopoulos
Journal:  Cancer Res       Date:  1989-06-15       Impact factor: 12.701

10.  E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.

Authors:  U H Frixen; J Behrens; M Sachs; G Eberle; B Voss; A Warda; D Löchner; W Birchmeier
Journal:  J Cell Biol       Date:  1991-04       Impact factor: 10.539

View more
  340 in total

Review 1.  HGF/SF in mammary epithelial growth and morphogenesis: in vitro and in vivo models.

Authors:  T Kamalati; B Niranjan; J Yant; L Buluwela
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-01       Impact factor: 2.673

2.  Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity.

Authors:  M Tsubari; J Taipale; E Tiihonen; J Keski-Oja; M Laiho
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 3.  Invasive growth: from development to metastasis.

Authors:  Paolo M Comoglio; Livio Trusolino
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 4.  Angiogenesis in hematologic malignancies and its clinical implications.

Authors:  Renchi Yang; Zhong Chao Han
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

5.  Modeling the early stages of vascular network assembly.

Authors:  Guido Serini; Davide Ambrosi; Enrico Giraudo; Andrea Gamba; Luigi Preziosi; Federico Bussolino
Journal:  EMBO J       Date:  2003-04-15       Impact factor: 11.598

6.  Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase.

Authors:  K Murakami; R Sakukawa; T Ikeda; T Matsuura; S Hasumura; S Nagamori; Y Yamada; I Saiki
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

7.  Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

Authors:  S Yi; M S Tsao
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

8.  Spatially directed guidance of stem cell population migration by immobilized patterns of growth factors.

Authors:  Eric D Miller; Kang Li; Takeo Kanade; Lee E Weiss; Lynn M Walker; Phil G Campbell
Journal:  Biomaterials       Date:  2011-01-26       Impact factor: 12.479

9.  NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.

Authors:  Takeshi Kubota; Hiroaki Taiyoh; Atsushi Matsumura; Yasutoshi Murayama; Daisuke Ichikawa; Kazuma Okamoto; Hitoshi Fujiwara; Hisashi Ikoma; Masayoshi Nakanishi; Shojiro Kikuchi; Chouhei Sakakura; Toshiya Ochiai; Yukihito Kokuba; Hiroki Taniguchi; Teruhisa Sonoyama; Kunio Matsumoto; Toshikazu Nakamura; Eigo Otsuji
Journal:  Clin Exp Metastasis       Date:  2009-02-21       Impact factor: 5.150

10.  Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver.

Authors:  M L Liu; W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.